Literature DB >> 28362980

Role of Th1/Th2 cytokines in the diagnosis and prognostic evaluation of ankylosing spondylitis.

J T Wen1, D H Zhang2, P F Fang3, M H Li3, R J Wang3, S H Li1.   

Abstract

Ankylosing spondylitis (AS), a progressive disease of the spine, manifests as peripheral arthritis with tendon and ligament inflammation that restricts activity. AS is a rheumatoid autoimmune disease although the rheumatoid factor is absent in patients with AS. It is characterized by inflammatory changes such as elevated levels of serum inflammatory factors. The roles of Th1 and Th2 cytokines in autoimmune diseases are well known. However, the roles of these cytokines in the diagnosis and prognosis of AS is poorly understood. The aim of this study was to investigate the roles of Th1/Th2 cytokines in the diagnosis and prognosis of AS. The BASDAI activity, BASFI functional index, BASMI measurement score, and the levels of CRP and ESR were measured during the treatment of patients with active AS. The levels of IFN-γ and TNF-α (Th1 cytokines) and IL-4 and IL-10 (Th2 cytokines) were quantified. The levels of IL-4 and IL-10 were significantly low in the serum of patients with active AS, who also had high IFN-γ and TNF-α levels compared to those in the control individuals (P < 0.05). After treatment, the levels of IL-4 and IL-10 increased while those of IFN-γ and TNF-α decreased compared to those in individuals with active AS (P < 0.05). The disease activity index correlated positively with levels of IFN-γ and TNF-α and negatively with levels of IL-4 and IL-10, but not with that of CRP or ESR. Changes in the levels of Th1/2 cytokines in patients with AS may reflect disease activity and prognosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28362980     DOI: 10.4238/gmr16019322

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  3 in total

1.  Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties.

Authors:  Seyed Shahabeddin Mortazavi-Jahromi; Sepideh Nazeri; Fahimeh Jafarnezhad-Ansariha; Mona Oraei; Abbas Mirshafiey
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

2.  Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation.

Authors:  Ewa Kuca-Warnawin; Iwona Janicka; Krzysztof Bonek; Ewa Kontny
Journal:  Cells       Date:  2021-01-30       Impact factor: 6.600

3.  Micheliolide alleviates ankylosing spondylitis (AS) by suppressing the activation of the NLRP3 inflammasome and maintaining the balance of Th1/Th2 via regulating the NF-κB signaling pathway.

Authors:  Zhong-Gu Tian; Miaomiao Yao; Jie Chen
Journal:  Ann Transl Med       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.